Olympiad Research’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-193,253
Closed -$3.61M 388
2022
Q1
$3.61M Buy
+193,253
New +$3.48M 1.1% 22

Other funds holding OCDX

Olympiad Research's OCDX Position: Q2 2022 in Review

Olympiad Research sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 193,253 shares — an estimated $3.61M sold.

Olympiad Research first reported a position in OCDX in Q1 2022 and held it in 1 quarter. The position peaked at $3.61M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Olympiad Research reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Olympiad Research sold 193,253 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $3.61M.
  • Olympiad Research first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2022 and held it in 1 quarter.
  • Olympiad Research's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $3.61M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Olympiad Research's 13F filing for Q2 2022, filed 8 Aug 2022.